News
10-05-2016, 04:51 PM
All 13 newly diagnosed breast cancer patients with BRCA mutations had their tumors shrink significantly when treated with a PARP inhibitor ahead of frontline presurgical chemotherapy in a pilot study at The University of Texas MD Anderson Cancer Center.
More... (http://www.news-medical.net/news/20161005/Treatment-using-PARP-inhibitor-shrinks-tumors-in-breast-cancer-patients-with-BRCA-mutations.aspx)
More... (http://www.news-medical.net/news/20161005/Treatment-using-PARP-inhibitor-shrinks-tumors-in-breast-cancer-patients-with-BRCA-mutations.aspx)